181 results on '"Michalski, A."'
Search Results
2. Expression of the EWSR1-FLI1 fusion oncogene in pancreas cells drives pancreatic atrophy and lipomatosis
3. Loss of TLR3 and its downstream signaling accelerates acinar cell damage in the acute phase of pancreatitis
4. Expression of Irf3 and Irf7 in tumour cells drives pancreatic cancer development and progression
5. PROTOCOL trial – PROTon pump inhibitors and stent OCclusion rate Of Lumen apposing metal stents
6. Location of tissue associated macrophages M2 in pancreatic cancer
7. Complement system genetic variability shapes pancreatic cancer risk
8. Safety of multimodality treatment with a combination of intra- operative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: The combiCaRe study
9. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
10. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy
11. Increased expression of Nodal correlates with reduced patient survival in pancreatic cancer
12. Irf3 and Irf7 are important mediators of tumor cell aggressiveness in pancreatic cancer
13. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer
14. Irf3 and Irf7 are important mediators of tumor cell aggressiveness in pancreatic cancer
15. Confirmation of DNA Microarray-Derived Differentially Expressed Genes in Pancreatic Cancer Using Quantitative RT-PCR
16. Defining New Pancreatic Tumour Entities by Molecular Analysis
17. Pancreatic Islet and Stellate Cells Are the Main Sources of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Pancreatic Cancer
18. AGR2 promotes the growth of pancreatic ductal adenocarcinoma by stimulating CAFs-derived IGF1 signaling in a paracrine manner
19. Epigenetic reprogramming of classical and basal-like pancreatic cancer subtypes
20. Leukocyte-DNA methylome explains a large proportion of the risk variability of pancreatic cancer
21. Leukocyte-DNA methylome explains a large proportion of the risk variability of pancreatic cancer
22. AGR2 promotes the growth of pancreatic ductal adenocarcinoma by stimulating CAFs-derived IGF1 signaling in a paracrine manner
23. Irf3 and Irf7 are important mediators of tumor cell aggressiveness in pancreatic cancer
24. Classical and basal-like pancreatic cancer subtypes exhibit a different epigenetic response
25. Anterior gradient 2 promotes early pancreatic cancer progression via Polr2a-ATR-p53 signal axis
26. Epigenetic reprogramming of classical and basal-like pancreatic cancer subtypes
27. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy
28. Anterior gradient 2 promotes early pancreatic cancer progression via Polr2a-ATR-p53 signal axis
29. Classical and basal-like pancreatic cancer subtypes exhibit a different epigenetic response
30. Activated stroma index in neoadjuvantly treated patients with pancreatic ductal adenocarcinoma
31. Anterior gradient 2 promotes early pancreatic carcinogenesis by suppressing p53 function
32. Analyzing the impact of epigenetic profiles on the reprogramming efficiency in different pancreatic cancer subtypes
33. Impact of Tlr3 on acinar-to-ductal metaplasia and pancreatic cancer progression
34. Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships
35. Activated stroma index in neoadjuvantly treated patients with pancreatic ductal adenocarcinoma
36. A diagnostic algorithm to predict malignant potential of pancreatic intraductal papillary mucinous neoplasms
37. Ring1b-mediated epigenetic silencing of acinar cell fate genes is a mandatory event in pancreatic carcinogenesis
38. Prognostic value of reliably assessed diabetes mellitus type 2 in pancreatic cancer
39. Anterior gradient 2 promotes early pancreatic carcinogenesis by suppressing p53 function
40. Increased expression of Nodal correlates with reduced patient survival in pancreatic cancer
41. T cells infiltrates evolve during pancreatic carcinogenesis of intraductal papillary mucinous neoplasms
42. A diagnostic algorithm to predict malignant potential of pancreatic intraductal papillary mucinous neoplasms
43. Analyzing the impact of epigenetic profiles on the reprogramming efficiency in different pancreatic cancer subtypes
44. Impact of Tlr3 on acinar-to-ductal metaplasia and pancreatic cancer progression
45. Ring1b-mediated epigenetic silencing of acinar cell fate genes is a mandatory event in pancreatic carcinogenesis
46. Mesenchymal Wt1 positive stellate cells represent a source of the fibrotic response in pancreatitis
47. Epigenetic mechanisms drive cellular reprogramming in pancreatic carcinogenesis
48. T cells infiltrates evolve during pancreatic carcinogenesis of intraductal papillary mucinous neoplasms
49. Chimeric oncogene EWS/FLI-1 induces adipocyte replacement in pancreas
50. Association between gallbladder disease and pancreatic cancer risk according to tumour characteristics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.